ATP1A2 and motor neuron disorder: Thus, to achieve at least 50% target reduction with minimal toxicity, we proceeded with two independent Atp1a2 targeting ASOs, ASO1 at 50μg and ASO3 at 25μg, to characterize effects of Atp1a2 knockdown in motor neuron disease in SOD1*G93A animals.